Global Financial Private Client, LLC Abbott Laboratories Transaction History

Global Financial Private Client, LLC

$262 Billion
Q1 2025

A detailed history of Global Financial Private Client, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Global Financial Private Client, LLC holds 2,375 shares of ABT stock, worth $317,561. This represents 0.12% of its overall portfolio holdings.

Number of Shares

2,375

Previous 2,320 2.37%

Holding current value

$317,561

Previous $262 Million 20.05%

% of portfolio

0.12%

Previous 0.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 07, 2025	BUY	$111.1 - $140.22 $6,110 - $7,712	55 Added 2.37%	2,375 $315 Million
Q4 2024 Jan 13, 2025	BUY	$111.93 - $119.39 $2,574 - $2,745	23 Added 1.0%	2,320 $262 Million
Q3 2024 Oct 07, 2024	BUY	$100.07 - $118.13 $43,730 - $51,622	437 Added 23.49%	2,297 $262 Million
Q2 2024 Jul 29, 2024	BUY	$100.73 - $112.44 $100 - $112	1 Added 0.05%	1,860 $193 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $2,518 - $2,782	23 Added 1.25%	1,859 $208 Million
Q4 2023 May 15, 2024	SELL	$90.19 - $110.4 $14,250 - $17,443	-158 Reduced 7.92%	1,836 $202 Million
Q3 2023 May 15, 2024	BUY	$95.53 - $114.62 $95 - $114	1 Added 0.05%	1,994 $191 Million
Q2 2023 May 15, 2024	SELL	$100.78 - $112.29 $2,015 - $2,245	-20 Reduced 0.99%	1,993 $214 Million
Q1 2023 May 15, 2024	BUY	$96.86 - $114.01 $15,400 - $18,127	159 Added 8.58%	2,013 $205 Million
Q4 2022 May 15, 2024	BUY	$95.06 - $111.52 $2,091 - $2,453	22 Added 1.2%	1,854 $204 Million
Q3 2022 May 15, 2024	BUY	$96.76 - $112.03 $8,127 - $9,410	84 Added 4.81%	1,832 $182 Million
Q1 2022 May 15, 2024	BUY	$114.02 - $139.04 $114 - $139	1 Added 0.06%	1,748 $207 Million
Q4 2021 May 15, 2024	BUY	$115.53 - $141.46 $115 - $141	1 Added 0.06%	1,747 $246 Million
Q2 2021 May 15, 2024	BUY	$105.79 - $124.53 $105 - $124	1 Added 0.06%	1,746 $205 Million
Q1 2021 May 15, 2024	BUY	$108.84 - $128.23 $108 - $128	1 Added 0.06%	1,745 $208 Million
Q4 2020 May 15, 2024	BUY	$105.0 - $114.42 $3,150 - $3,432	30 Added 1.75%	1,744 $191 Million
Q3 2020 May 15, 2024	BUY	$91.64 - $111.29 $15,853 - $19,253	173 Added 11.23%	1,714 $186 Million
Q2 2020 May 15, 2024	SELL	$76.57 - $98.0 $14,242 - $18,228	-186 Reduced 10.77%	1,541 $141 Million
Q1 2020 May 15, 2024	BUY	$62.82 - $91.86 $9,925 - $14,513	158 Added 10.07%	1,727 $132 Million
Q4 2019 May 15, 2024	BUY	$78.51 - $87.4 $123,182 - $137,130	1,569 New	1,569 $136 Million

Others Institutions Holding ABT

# of Institutions

3,541

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $234B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Financial Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Financial Private Client, LLC with notifications on news.

Account

Global Financial Private Client, LLC Abbott Laboratories Transaction History